{
    "code": "02023396",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023396",
    "time": "2017-04-14 03:29:28",
    "許可證字號": "衛署藥輸字第023396號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/03\/11",
    "發證日期": "91\/03\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202339606",
    "中文品名": "安莎德斯注射液",
    "英文品名": "Anzatax  Injection Concentrate",
    "適應症": "晚期卵巢癌、腋下淋巴轉移之乳癌，作為接續含杜薩魯比辛(DOXORUBICIN)在內之輔助化學療法、已使用合併療法(除非有禁忌，至少應包括使用ANTHRACYCLINE抗癌藥)失敗的轉移乳癌、非小細胞肺癌、愛滋病相關卡波西氏肉瘤之第二線療法。",
    "劑型": "270注射劑",
    "包裝": "5公撮,16.7公撮,25公撮,50公撮小瓶 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "PACLITAXEL"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620102S342  新加坡商赫士睿股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F020031100  HOSPIRA AUSTRALIA PTY LTD.",
        "製造廠廠址": "1-5, 7-23 AND 25-39 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000100",
            "成分名稱": "PACLITAXEL",
            "含量描述": "",
            "含量": "6.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "P02339602安莎德斯注射液(29.7x42cm)-106-03-26(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023396&Seq=006&Type=9"
        },
        {
            "title": "023396 安莎德斯注射液 Anzatax Conce.100mg Inj. 16.7ml-瓶身外盒-104-10-14(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023396&Seq=004&Type=8"
        }
    ]
}